EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery
暂无分享,去创建一个
L. Kleinberg | Thomas Fleischer | Å. Helland | O. Brustugun | S. Solberg | S. Ariansen | C. Sagerup | A. K. Rud | Lars N Jørgensen | T. Fleischer | Hege Marian Skaug | Marius Lund Iversen
[1] E. Imyanitov,et al. High Efficacy of First-Line Gefitinib in Non-Asian Patients with EGFR-Mutated Lung Adenocarcinoma , 2010, Oncology Research and Treatment.
[2] Lin Huan,et al. Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer , 2010 .
[3] T. Mok,et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. , 2009, The New England journal of medicine.
[4] Pedro Mendez,et al. Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer. , 2005, Lung cancer.
[5] Takayuki Kosaka,et al. Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer , 2004, Cancer Research.
[6] R. Wilson,et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[8] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[9] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .